SKSüleyman Gökhan Kara

Süleyman Gökhan Kara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Süleyman Gökhan Kara has a total of 152 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Olgular Eşliğinde Acil Tıp

    by Özgür Karcıoğlu, Kübra Parpucu Bağçeci, Eray Çeliktürk, Tahir Talat Yurttaş, Müslime Kasa, Mustafa Eymen Kontaş, Volkan Ercan, Eda Ferahkaya, Keziban Turgut, Nazan Dolapoğlu, et al.

  • Batın İçi Kanaması Olan Multitravma Hastasında Eşzamanlı Miyokard İnfarktüsü Yönetimi: Olgu Sunumu

    by Süleyman Gökhan Kara

    Akut miyokard infarktüsü (MI) tedavisinde erken revaskülarizasyon ve agresif antitrombotik tedavi esastır. Ancak bu durumun masif kanama riski taşıyan çoklu solid organ yaralanmaları ile eşzamanlı görülmesi, hekimleri kanama ve tromboz paradoksuyla karşı karşıya bırakır. Bu olgu sunumunda, majör travma ve akut MI'ın bir arada görüldüğü kompleks bir hastanın multidisipliner yönetimi tartışılmaktadır. Alkol intoksikasyonu (200 mg/dL) eşliğinde motosiklet kazası geçiren 38 yaşındaki erkek hasta acil servise getirilmiştir. Hastanın elektrokardiyografisinde (EKG) akut inferior ST elevasyonu saptanırken, travma görüntülemelerinde toraksta çoklu kosta kırıkları, batında ise grade 3 dalak ve grade 2-3 sol böbrek laserasyonları ile pelvik serbest sıvı tespit edilmiştir. Acil multidisipliner konsey kararıyla kardiyoloji tarafından anjiyografiye alınan hastada sağ koroner arter (RCA) total tıkalı bulunmuştur. Acil cerrahi ihtimali ve majör kanama riski nedeniyle stent implantasyonu ve kesintisiz dual antiplatelet tedaviden (DAPT) kaçınılarak, "hasar kontrol" stratejisiyle yalnızca balon anjiyoplasti ve trombüs aspirasyonu uygulanmış, TIMI-2 akım (Kısmi perfüzyon) sağlanmıştır. Yoğun bakım takibinde batın distansiyonu ve kanaması artan hastaya acil splenektomi uygulanmıştır. Postoperatif 48. saatte cerrahi hemostazın kanıtlanmasının ardından asetilsalisilik asit (ASA) ve sonrasında düşük molekül ağırlıklı heparin (DMAH) başlanarak antitrombotik tedavi gecikmeli olarak indüklenmiş, hasta şifa ile taburcu edilmiştir. Majör travma ve eşzamanlı akut MI yönetiminde, ileri travma yaşam desteği (ATLS) ve kardiyoloji kılavuzlarının zıt tedavi yaklaşımları birbiriyle çatışmaktadır. Bu tür kompleks kriz anlarında birçok kılavuzu beraber değerlendirip, hastanın anlık fizyolojisini merkeze alan multidisipliner yaklaşımlar morbidite ve mortaliteyi azaltmada hayat kurtarıcıdır.

  • The Effect of Wharton s Jelly Mesenchymal Stem Cell Application on Haematological Parameters in Cows with Subclinical Mastitis

    by Ayşegül BULUT, Merve Nur Soykan, Fatih Aladağ, Ayla Eker Sariboyaci, Durmuş HATİPOĞLU, Onur Uysal, Sibel Güneş Bağiş, Süleyman Gökhan Kara, Bahar Demi̇r Cevi̇zLi̇dEre, Burcugül Altuğ, et al.

    This study aimed to investigate the effect of intramammary Wharton's Jelly mesenchymal stem cell (WJ-MSC) administration on haematological parameters in cows with subclinical mastitis. In the study, 20 Holstein cows kept under equal care and feeding conditions during the same lactation period were used. The California Mastitis Test (CMT) was applied to identify animals with subclinical mastitis. Animals were divided into 4 groups: control (n=4, 3 ml DMEM solution, intramammary, days 2 and 9), Wharton's Jelly mesenchymal stem cells (n=4, WJ-MSCs, 2.5 x 107 WJ-MSCs, intramammary, days 2 and 9), subclinical mastitis (n=6, SM, parenteral antibiotic treatment, days 2 and 9), and SM+WJ-MSCs (n=6, 2.5 x 107 WJ-MSCs, days 2 and 9). On the 1st and 30th days of the study, blood samples were taken directly from the jugular vein under aseptic conditions into EDTA tubes containing anticoagulant for the evaluation of haematological parameters. Parameters related to infection and inflammation were evaluated in blood count analyses. It was found that the reference ranges for the parameters leukocyte (WBC), erythrocyte (RBC), haemoglobin (HGB), haematocrit (HCT), platelet (PLT), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), neutrophil percentage Neu (%), and lymphocyte percentage (Lym%) varied. The WBC value, which was above the reference range on day 1, was measured within the reference range on day 30. It was found that the Neu% value, which was above the reference value in the Day 1 measurement, and the Lym% value, which was below the reference value, were within the reference values in the post-treatment measurement. The results obtained indicate that the application of WJ-MSCs has no negative effect on haematological parameters and may even play a balancing role in the inflammatory response for some parameters due to its immunomodulatory effects.

  • Open Access

    Clinical feasibility and cost efficiency of perinatal mesenchymal stem cell production under GMP conditions

    by Mehmet Çopuroğlu, Ömer Tarık Yalçın, Süleyman Gökhan Kara

    Perinatal tissues such as umbilical cord, amniotic fluid, amniotic membrane, and placenta contain mesenchymal stem cells (MSCs) with clinical potential; however, a direct comparison of these sources under Good Manufacturing Practice (GMP) conditions remains limited. To evaluate and compare perinatal tissue types in terms of viable MSC yield, sterility, and GMP-adjusted processing cost in order to identify practically applicable sources for clinical-grade biobanking. A total of 160 perinatal tissue samples were collected from 32 term pregnancies during elective cesarean delivery. Standardized GMP protocols were applied for MSC isolation, sterility screening using automated BACTEC™ culture systems, and immunophenotypic characterization in accordance with ISCT criteria. Multivariate linear regression was used to identify independent predictors of MSC yield. Cost modeling included reagents, labor, and cryostorage within a laboratory-scale GMP setting. Umbilical cord tissue yielded the highest number of viable MSCs (6.5 × 10⁶ ± 0.8 cells/sample), followed by amniotic fluid (5.8 × 10⁶ ± 0.6). Amniotic fluid exhibited the lowest contamination rate (3%), whereas placental tissues demonstrated higher microbial burden (18–21%). Tissue type was the strongest predictor of MSC yield (β = 0.61, p < 0.001). Normalized cost analyses indicated that umbilical cord and amniotic fluid offered the most favorable yield-to-cost profiles. Under current GMP conditions, umbilical cord and amniotic fluid appear to provide the most balanced combination of MSC yield, sterility, and processing cost. These findings support a practical framework for tissue selection and workflow optimization in perinatal MSC biobanking and translational regenerative applications.


  • Comprehensive evaluation of the clinical feasibility of using perinatal medical waste as a source for fetal mesenchymal stem cell banking under good manufacturing practice conditions

    by Mehmet Çopuroğlu, Ömer Tarık Yalçın, Süleyman Gökhan Kara

    This study aimed to determine the most feasible perinatal tissue for Good Manufacturing Practice (GMP)-compliant banking of mesenchymal stromal-like cells (MSC-like cells). It was hypothesized that amniotic fluid collected during cesarean section would yield lower contamination rates and greater processing feasibility compared with other perinatal tissues. This prospective observational study was conducted at a tertiary university hospital and included 32 healthy term pregnancies. A total of 160 perinatal samples—amniotic fluid, amniotic membrane, umbilical cord, intact placenta, and placental fragments—were obtained. A validated feasibility scoring system evaluated material acquisition difficulty, transportation logistics, storage duration, and processing complexity. Samples were stratified by delivery mode (cesarean section vs. vaginal delivery) and collection timing (within vs. outside laboratory working hours). Stem cell isolation, sterility assessment, and immunophenotypic characterization were performed. Due to the absence of trilineage differentiation assays and maternal–fetal origin confirmation, the isolated cells were defined as MSC-like cells rather than definitive fetal MSCs. Statistical analyses were performed using chi-square and Mann–Whitney U tests (p < 0.05). Samples collected via cesarean section demonstrated significantly lower rates of blood contamination (25.8% vs. 60.0%, p < 0.001) and bacterial contamination (25.8% vs. 60.0%, p < 0.001) compared with those from vaginal deliveries. Amniotic fluid achieved the highest acquisition score, required no enzymatic digestion, and had the shortest median isolation time (45 min). It exhibited the lowest overall contamination and was the most suitable source for GMP-oriented MSC-like cell processing. Conversely, intact placenta and placental fragments showed the highest contamination rates, longest enzymatic processing times, and greatest logistical burden. While collection timing affected storage duration and workflow continuity, tissue type and delivery mode were the dominant determinants of feasibility. Cesarean section-derived amniotic fluid appears to be the most practical, sterile, and processing-efficient perinatal source for GMP-adapted MSC-like cell banking within the evaluated parameters. These results support its prioritization in the development of standardized collection and processing protocols for perinatal stromal cell applications in regenerative medicine.


  • Open Access

    Predicting mortality and safe discharge in drowning victims: A comprehensive analysis of neurological and clinical outcomes in the emergency department

    by Süleyman Gökhan Kara, Başak Bayram, Şebnem Şakar Halaç, Osman Sönmez, Neşe Çolak

    OBJECTIVES: This study sought to identify risk factors linked to mortality, intensive care unit admission, and poor neurological outcomes among drowning victims and to find markers for safe discharge from the emergency department (ED). METHODS: This retrospective cross-sectional study evaluated all drowning victims presenting to both adult and pediatric EDs at a single center over an 11-year period. Variables such as arrival time at ED, age, type of water, comorbid diseases, vital signs, treatments given, and prehospital interventions were assessed. RESULTS: The study found that early basic life support (BLS) by bystanders significantly improves survival and neurological outcomes. Respiratory rate, oxygen saturation, and Glasgow Coma Scale (GCS) were identified as independent risk factors for poor clinical outcomes. While the Szpilman clinical score is useful, it alone is not sufficient for predicting poor clinical outcomes. CONCLUSIONS: For optimal management of drowning victims, immediate BLS is crucial. In the ED, respiratory rate, oxygen saturation, and GCS should be closely monitored. Drowning victims with a GCS of 15, normal respiratory rate, normal oxygen saturation, and Szpilman score below 3 can be safely discharged from the ED.


  • Open Access

    Establishment, culture and characterization of gemcitabine hydrochloride‐resistant human non‐small cell lung carcinoma cell line derived cancer stem cells

    by Bahar Demir Cevizlidere, Onur Uysal, Huseyin Avci, Sibel Gunes Bagis, Tugba Semerci Sevimli, Murat Dincer, Emilia Qomi Ekenel, Suleyman Gokhan Kara, Merve Nur Soykan, Ayla Eker Sariboyaci

    Due to their high expression profile of multi‐drug resistance genes, cancer stem cells (CSCs) are the main source of drug resistance. The aim of this study was to establish a gemcitabine‐hydrochloride‐resistant (rt) human non‐small cell lung cancer (hNSCLC) cell line and their CSC line to be used as disease models in various cancer studies. In the first phase of study, a gemcitabine hydrochloride‐rt hNSCLC line cells was produced by making them rt through periodic exposure to gemcitabine hydrochloride. This acquired gemcitabine‐hydrochloride‐rt hNSCLC cell line was characterized for resistance. Subsequently, a CSC population with a CD326 + CD133 + CD44+ phenotypes was immunoselectively isolated from gemcitabine hydrochloride‐rt hNSCLCs purified from a single cell by colony forming technology. This rt CSC line was characterized for both resistance and stemness. Rt and non‐rt CSCs were analyzed and compared with each other in terms of immunophenotyping the expression profiles of ALDH1, CD90, ABCG2, CD44 and MDR1, which are CSC specific markers, of demonstrating mitotic capacity with growth curve analysis and of their ability to form tumor spheroids in three different 3D cultures. The results of this study demonstrated for the first time the successful generation of both gemcitabine‐hydrochloride‐rt hNSCLC cells and CSCs derived from gemcitabine‐hydrochloride‐rt hNSCLC cells. It was also shown that isolated and characterized rt CSCs could proliferate and form tumor spheres in vitro using three different 3D in vitro techniques. It was shown that the cell surface markers CD326, CD133 and CD44 can serve as an antibody panel for CSCs.


  • Open Access

    Comparison of three supraglottic airway devices for blind tracheal intubation by novice practitioners: A randomized manikin study

    by Osman Sonmez, Nese Colak, Basak Bayram, Suleyman Gokhan Kara, Sebnem Sakar Halac

    OBJECTIVES: Supraglottic airway (SGA) devices are good alternatives for failed intubations or difficult airways. The aim of our study was to compare the success of intubation with SGA devices such as LMA Fastrach® (LMA Fastrach), Ambu Aura-i® (Aura-i), and Cookgas Air-Q® (Air-Q) in an airway manikin by novice practitioners. METHODS: This study was conducted in a randomized crossover design using a manikin model. Following training on the equipment used, 36 6th-year medical students were randomized into six groups. Participants performed three stages of intubation as follows: the first stage (1S) as SGA insertion, the second stage (2S) as intubation through the SGA, and the third stage (3S) as the removal of the SGA over the intubation tube. The primary outcomes were intubation success and duration. RESULTS: The successful intubation rate (Stage 1S + 2S + 3S) was 100% for LMA Fastrach and Air-Q and 83.3% for Aura-i (P = 0.002). The median time to intubation was 54.4 s, 55.8 s, and 58.7 s for LMA Fastrach, Aura-i, and Air-Q, respectively (P = 0.794). CONCLUSION: Our study shows that novice practitioners can proficiently utilize LMA Fastrach, Air-Q, and Aura-i as SGAs in airway management. LMA Fastrach and Air-Q are more successful for endotracheal intubation than Aura-i. While the successful intubation time with SGA is similar for all three devices, the successful SGA insertion time is shorter with LMA Fastrach and Aura-i compared to Air-Q. Practitioners preferred LMA Fastrach and Air-Q more than Aura-i.